Comments
Commented by André Will-Laudien on July 29th, 2026 | 07:50 CEST
Active Ingredients, Acquisitions and Spin-offs: Will Bayer, Novo Nordisk, BioNxt, or Evotec Become Top M&A Targets?
After years of consolidation, investors are asking: Will things start looking up again? The global life sciences sector is facing another massive wave of consolidation in 2026 as established pharmaceutical giants and agile biotech pioneers realign their businesses. Market dynamics remain high, but unfortunately, both sides are being exploited. So far, it has been predominantly speculative investors who are capitalizing on the current volatility. Following drastic share price losses and ongoing restructuring, the struggling Hamburg-based biotech company Evotec is increasingly in the crosshairs of financially strong acquirers seeking to acquire high-calibre drug discovery platforms at a bargain price. At the same time, BioNxt is attracting investor interest with its groundbreaking drug delivery systems and advanced clinical pipelines. Meanwhile, the market continues to speculate feverishly about a possible breakup or spin-off of individual divisions at the DAX-listed Bayer Group, which would massively increase its appeal to strategic buyers. On the other hand, Danish industry leader Novo Nordisk, driven by the sustained billion-dollar profits from its weight-loss portfolio, is acting as a financially powerful hunter in search of strategic acquisitions in the obesity and cardiovascular segments. For investors, this highly dynamic environment offers a rare opportunity to bet early on the year's hottest takeover candidates. What is the current status?
Read
Commented by Nico Popp on July 29th, 2026 | 07:45 CEST
Battery Metals Bottleneck: Volkswagen and BHP Under Pressure as Power Metallic Mines Faces Weeks of Truth
Electric vehicles are becoming an increasingly common sight on German roads, driven in part by the arrival of aggressively priced models from China. However, the rapid growth of electric mobility is placing mounting pressure on automotive supply chains. Automakers are grappling with volatile markets while becoming increasingly concerned about securing reliable access to critical raw materials. Commodities are no longer viewed as readily available inputs but as strategic assets essential to industrial competitiveness. This complex situation calls for new alliances: mining companies, major automakers, and dynamic project developers are pulling out all the stops to secure raw materials for the future.
Read
Commented by Armin Schulz on July 29th, 2026 | 07:40 CEST
Billion-Dollar Markets of Obesity, Oncology, and Neurology in Focus: Novo Nordisk, Vidac Pharma, and AbbVie
The healthcare industry of the future is driven by three major megatrends: obesity, oncology, and neurology. While the market for cancer drugs is heading toward nearly USD 700 billion and Alzheimer's therapies are booming, the GLP-1 boom has only just begun and has replaced oncology as the largest driver of pipeline value. But not every company will benefit equally from this momentum. The key difference lies in strategic focus and the ability to translate scientific milestones into market success. We take a look at three companies today—Novo Nordisk, Vidac Pharma, and AbbVie—each of which embodies one of these areas.
Read
Commented by Matthias Schomber on July 29th, 2026 | 07:35 CEST
Deutz, Jungheinrich, and Almonty: Where Investors Can Find Real Opportunities in the Market Right Now
The European industrial landscape is currently noticeably fragmented, which presents investors with difficult decisions about which stocks will perform well and which will perform poorly. While it has never been easy to make the right choice, as established, long-standing German corporations grapple with rising material costs, intense price pressure, and, in some cases, the aftermath of internal conflicts, interest is increasingly shifting toward companies in strategic niche markets, including the commodities and defense sectors. The stocks of Deutz and Jungheinrich reflect the current challenges facing the broader mechanical engineering sector, which is suffering from noticeable margin pressure despite solid order intake. Defense, however, is a buzzword that could boost the performance of one or two stocks in that sector—if handled skillfully. At the same time, the spotlight is on commodity stocks that are benefiting from global geopolitical upheavals. Almonty Industries, in particular, is drawing attention due to an exciting consolidation pattern on the charts. Can this tungsten heavyweight soon regain its former strength? This report examines the current situation of the three stocks and highlights where real opportunities might now be emerging!
Read
Commented by Fabian Lorenz on July 29th, 2026 | 07:30 CEST
Helsing IPO in 2027? Hensoldt Expands Drone Partnership as First Hydrogen Eyes Robotics Re-Rating
Could Helsing go public as early as next year? The defence technology company is currently valued at a whopping USD 18 billion. To justify that valuation, Helsing is developing, among other things, the CA-1 Europa autonomous combat aircraft. Hensoldt is supporting this effort, and the partnership was recently expanded. Meanwhile, First Hydrogen is broadening its business model. CEO Balraj Mann increasingly views autonomous systems as a key technology in light of changes in the defence, security, and disaster response sectors. By building in-house AI expertise, the company aims to further develop its UGV program for autonomous navigation, situational awareness, and counter-drone capabilities, while simultaneously expanding its strategy at the intersection of clean energy, mobility, and robotics. If successful, these initiatives could provide the catalyst for a re-rating of the company's shares.
Read
Commented by Lars Winter on July 29th, 2026 | 07:20 CEST
New Buy Recommendations for Evonik, Fuchs, and Zefiro Methane: Analysts See Price Potential of Over 240%
Fresh Buy recommendations are fueling new price momentum for Zefiro Methane, Evonik, and Fuchs. The outlook for Zefiro is particularly spectacular. Following the turnaround in its operating performance, GBC believes the stock could multiply in value. But analysts are also forecasting double-digit price gains for the two German chemical stocks. When analysts raise their forecasts and recommend buying a stock, it is often worth taking a closer look. It becomes particularly interesting when these optimistic assessments are backed up by surprisingly strong financial results. That is exactly the case right now with Zefiro Methane, Evonik, and Fuchs. While the two German companies are already operating profitably and impressing with strong quarterly results, Zefiro is only at the beginning of a potential revaluation. The upside potential is correspondingly greater, though the risk is higher as well.
Read
Commented by Jens Castner on July 29th, 2026 | 07:15 CEST
Oversold? Kostolany Buy Signals Emerge for Rheinmetall, Lahontan Gold and Coinbase
Hopes for a lasting ceasefire between the US and Iran are driving stock prices higher. Oil prices are falling, and inflation concerns are easing. Even in such a supportive environment, however, investors should avoid buying indiscriminately. Legendary investor André Kostolany coined the rule: when prices ignore bad news, panic selling has ended. In other words, those who wanted to sell have already done so. This pattern now appears to be emerging in three very different stocks. The German defence contractor Rheinmetall, the Canadian exploration company Lahontan Gold, and the US crypto platform Coinbase have all retreated significantly from their respective highs. Yet, each has recently absorbed negative news without suffering further meaningful declines—potentially signalling that sentiment has begun to stabilize.
Read
Commented by Carsten Mainitz on July 29th, 2026 | 07:10 CEST
Steel Is Strategic Again: How Strategic Resources and thyssenkrupp Could Benefit—and What It Means for TKMS
Geopolitical tensions, rising defence spending, the energy transition and the drive for more secure supply chains are placing renewed emphasis on industrial production and strategic materials. Without metals, specialty alloys, and high-performance materials, neither modern defence systems nor next-generation technologies can function. Strategic Resources is positioning itself at the heart of these critical trends. The company continues to advance its flagship BlackRock project in Canada. On the one hand, the Canadians aim to supply high-grade iron ore for the production of "green steel," which aligns with the megatrend of decarbonization. At the same time, however, the company has several additional growth opportunities up its sleeve.
Read
Commented by Nico Popp on July 29th, 2026 | 07:05 CEST
Big Money in Sustainability – SAP and Siemens Energy Are Raking It In – RE Royalties Delivers a 10% Dividend
The transition to clean electricity is not failing for lack of will, but because of the enormous practical hurdles. While the rise of artificial intelligence is fueling demand for green energy, existing power grids worldwide are reaching their limits. At the same time, smaller project developers in this niche are grappling with financing and regulatory issues, while industrial conglomerates are required to disclose their carbon footprints with ever-greater transparency. Investors looking to capitalize on this complex situation must understand the various players and the challenges they face. We provide an overview and introduce a little-known hidden gem.
Read
Commented by Stefan Bode on July 29th, 2026 | 07:00 CEST
US Uranium Independence in Focus, T-Mobile US Under Pressure, Volkswagen Cuts Forecast – American Atomics, Deutsche Telekom, Porsche
The Iran war and the potential for escalation into neighbouring countries remain firmly on investors' radar despite the temporary pause in US air strikes. This report examines current developments at companies from various sectors that are currently attracting market attention. Whether it is strategic realignments to secure critical raw materials, turbulent share price reactions among telecommunications giants following earnings season, or the margin challenges facing European automakers in the Asian market—the latest market data offers plenty of potential for volatility. Find out which fundamental metrics and trends are now becoming decisive for investors.
Read